Filippo Petti was appointed Chief Executive Officer of Leucid Bio in July 2023. He brings broad industry expertise to Leucid Bio across operations, finance and research. Prior to joining Leucid, he was CEO, CFO and Executive Director of Celyad Oncology SA, a biotech company focused on cell therapies for cancer. Prior to Celyad Oncology SA, Mr. Petti spent several years as a healthcare investment banker at Wells Fargo Securities and William Blair & Company, where he specialised in working with cell and gene therapy companies. In addition, Mr. Petti has worked in equity research covering U.S. biotechnology companies both at William Blair & Company and Wedbush Securities. He began his career as a research scientist at OSI Pharmaceuticals, Inc. focused on drug discovery and translational research, before transitioning to corporate development with the company. Mr. Petti holds a Master of Business Administration from Cornell University, a Master of Science from St. John’s University and a Bachelor of Science from Syracuse University.